Herold Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50	Closed	-$4.69K	–	489
2022 Q1	$4.69K	Buy	+50	New	+$4.69K	﹤0.01%	673
2021 Q4	–	Sell	-150	Closed	-$14K	–	478
2021 Q3	$14K	Buy	+150	New	+$14K	0.01%	559